drugset
Drugs / TNFα Monoclonal Antibody
last change Aug 2023 re-read 3 minutes ago

TNFα Monoclonal Antibody

Monoclonal antibody

Developed for
spinal cord injury
Investigated by
904th Hospital of the Joint Logistics Support Force of the PLA · Kunshan Hospital of Traditional Chinese Medicine · Shanghai Changzheng Hospital · The First People's Hospital of Kunshan · The Sixth People's Hospital of Nantong, China · Zhejiang Provincial Hospital of TCM

Trials 1

today NCT04988425 · Ph 1/2
2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT04988425 Sep 2022 → Aug 2023 spinal cord injury Shanghai Changzheng Hospital Unknown No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TNFα Monoclonal Antibody ClinicalTrials.gov intervention name — accepted as the source's own label NCT04988425 ↗
Action Inhibit “TNF-α inhibitor” NCT04988425 ↗
Modality Monoclonal antibody “TNFα monoclonal antibody” NCT04988425 ↗
Route Subcutaneous “Subcutaneous injection” NCT04988425 ↗